Clinical Trial Update: Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury. [Phase 3]

View source ↗

Summary

Phase 3 trial of risedronate to prevent osteoporosis in individuals with spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Toronto Rehabilitation Institute | Conditions: Acute Spinal Cord Injury. | Phase 3 | Status: COMPLETED